ENDO: CUSTOMER PACT TO HIT LIDODERM SALES

Endo Pharmaceuticals Holdings Inc. said Monday net sales of its best selling product Lidoderm will fall below underlying demand during the third quarter as one of its major customers pares down current inventory of the drug.

Yahoo Finance (http://biz.yahoo.com/ap/061002/endo_outlook.html?.v=2)